Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs TeraWulf Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while TeraWulf Inc trades at $10.9 (market cap $5.75B). The key difference: Oruka Therapeutics Inc. Common Stock and TeraWulf Inc are close in size by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and TeraWulf Inc for 18 Days on average.
| ORKA | WULF | |
|---|---|---|
Market Cap | $5.08B | $5.75B |
Volume | 685,276 | 57,657,081 |
Sector | Health | Financials |
52-Week High | $113.08 | $28.98 |
52-Week Low | $26.19 | $10.99 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $4.21B | $8.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WULF trades at $13.21, down 1.2% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $661.42 million in 2025, with a negative net income margin of -1,179.94%, while revenue was $168.46 million. Analyst consensus is unanimously bullish with a $34.92 price target, and recent news highlights the company's pivot to AI data centers, driving investor interest despite financial losses.
The outlook is mixed: strong analyst support and AI infrastructure potential offer upside, but persistent losses, high valuation ratios, and negative cash flow from operations pose significant risks. Investors should weigh the growth narrative against fundamental weaknesses and sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
